Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates

The lethality of patients with ovarian cancer (OC) remains high. Current treatment strategies often do not lead to the desired outcome due to the development of therapy resistance, resulting in high relapse rates. Additionally, clinical trials testing immunotherapy against OC have failed to reach si...

Descripción completa

Detalles Bibliográficos
Autores principales: Berckmans, Yani, Hoffert, Yannick, Vankerckhoven, Ann, Dreesen, Erwin, Coosemans, An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385967/
https://www.ncbi.nlm.nih.gov/pubmed/37513979
http://dx.doi.org/10.3390/pharmaceutics15071792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385967/
https://www.ncbi.nlm.nih.gov/pubmed/37513979
http://dx.doi.org/10.3390/pharmaceutics15071792

Ejemplares similares